| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Torley Helen | PRESIDENT AND CEO, Director | C/O HALOZYME THERAPEUTICS, INC., 12390 EL CAMINO REAL, SAN DIEGO | /s/ James R. Oehler, Attorney-in-Fact | 17 Feb 2026 | 0001528185 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HALO | Common Stock | Options Exercise | $0 | +21,009 | +3% | $0.000000 | 729,728 | 16 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $900,373 | -11,334 | -1.6% | $79.44 | 718,394 | 16 Feb 2026 | Direct | F1 |
| transaction | HALO | Common Stock | Options Exercise | $0 | +16,875 | +2.3% | $0.000000 | 735,269 | 16 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $723,222 | -9,104 | -1.2% | $79.44 | 726,165 | 16 Feb 2026 | Direct | F2 |
| transaction | HALO | Common Stock | Options Exercise | $0 | +51,171 | +7% | $0.000000 | 777,336 | 16 Feb 2026 | Direct | |
| transaction | HALO | Common Stock | Tax liability | $2,192,941 | -27,605 | -3.6% | $79.44 | 749,731 | 16 Feb 2026 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HALO | Restricted Stock Units | Options Exercise | $0 | -21,009 | -100% | $0.000000 | 0 | 16 Feb 2026 | Common Stock | 21,009 | $0.000000 | Direct | F4 |
| transaction | HALO | Restricted Stock Units | Options Exercise | $0 | -16,875 | -50% | $0.000000 | 16,874 | 16 Feb 2026 | Common Stock | 16,875 | $0.000000 | Direct | F4 |
| transaction | HALO | Performance Stock Units | Options Exercise | $0 | -51,171 | -100% | $0.000000 | 0 | 16 Feb 2026 | Common Stock | 51,171 | $0.000000 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The reported disposition of 11,334 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F2 | The reported disposition of 9,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F3 | The reported disposition of 27,605 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| F4 | This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| F5 | This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |